Richard Bartram - Net Worth and Insider Trading

Richard Bartram Net Worth

The estimated net worth of Richard Bartram is at least $18,080 dollars as of 2024-09-24. Richard Bartram is the CFO of Esperion Therapeutics Inc and owns about 11,092 shares of Esperion Therapeutics Inc (ESPR) stock worth over $18,080. Details can be seen in Richard Bartram's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard Bartram has not made any transactions after 2019-04-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Richard Bartram

To

Richard Bartram Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Richard Bartram owns 1 companies in total, including Esperion Therapeutics Inc (ESPR) .

Click here to see the complete history of Richard Bartram’s form 4 insider trades.

Insider Ownership Summary of Richard Bartram

Ticker Comapny Transaction Date Type of Owner
ESPR Esperion Therapeutics Inc 2019-04-03 Chief Financial Officer

Richard Bartram Latest Holdings Summary

Richard Bartram currently owns a total of 1 stock. Richard Bartram owns 11,092 shares of Esperion Therapeutics Inc (ESPR) as of April 3, 2019, with a value of $18,080.

Latest Holdings of Richard Bartram

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ESPR Esperion Therapeutics Inc 2019-04-03 11,092 1.63 18,080

Holding Weightings of Richard Bartram


Richard Bartram Form 4 Trading Tracker

According to the SEC Form 4 filings, Richard Bartram has made a total of 0 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years. The most-recent trade in Esperion Therapeutics Inc is the sale of 8,000 shares on April 3, 2019, which brought Richard Bartram around $343,040.

Insider Trading History of Richard Bartram

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Richard Bartram Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Richard Bartram Ownership Network

Ownership Network List of Richard Bartram

No Data

Ownership Network Relation of Richard Bartram

Insider Network Chart

Richard Bartram Owned Company Details

What does Esperion Therapeutics Inc do?

Who are the key executives at Esperion Therapeutics Inc?

Richard Bartram is the Chief Financial Officer of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Operating Officer Sheldon L. Koenig , Chief Commercial Officer Eric Warren , and Chief Medical Officer Joanne M. Foody .

Esperion Therapeutics Inc (ESPR) Insider Trades Summary

Over the past 18 months, Richard Bartram made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 7,687 shares made by Eric Warren , a net sale of 5,140 shares made by Joanne M. Foody , and a net purchase of 5,450 shares made by Sheldon L. Koenig .

In summary, during the past 3 months, insiders sold 18,394 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 18,394 shares. During the past 18 months, 28,667 shares of Esperion Therapeutics Inc (ESPR) were sold and 59,611 shares were bought by its insiders, resulting in a net purchase of 30,944 shares.

Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Esperion Therapeutics Inc Insider Transactions

No Available Data

Richard Bartram Mailing Address

Above is the net worth, insider trading, and ownership report for Richard Bartram. You might contact Richard Bartram via mailing address: C/o Esperion Therapeutics, Inc., 3891 Ranchero Drive, Suite 150, Ann Arbor Mi 48108.

Discussions on Richard Bartram

No discussions yet.